New Product Planning
Our blend of clinical development experience, marketing toolbox and therapeutic expertise uniquely positions our team to support the pharmaceutical new product planning and development process. We have a long history of assisting clients in developing and implementing strategies that ensure differentiation and maintained product access for patients. Our success is driven by a deep understanding of the nuances of relevant markets and products which informs realistic, targeted and data-driven recommendations.
Herspiegel Consulting delivers strategic assessments and insightful processes in new product planning thus creating a structure for decision making. We help advance the development process with actionable insights to evaluate market potential, prioritize launch markets and develop competitive lifecycle management plans.
Recent Projects Include:
• Market landscape assessment and opportunity sizing
• Global disease strategy at corporate, BU and asset level strategy
• Early assets management including stage gate decision support
• Launch prioritization
• Creation of a dynamic forecast model
• Investor deck development
• Lifecycle management plan
FDA Continued Rejections of Citizen Petitions Highlights Key Lifecycle Challenges for Biologic ManufacturersJanuary 24, 2018
Citizen petitions have historically been a tool in the brand manufacturer’s toolkit of “product life...Read more
The FDA approved Dupixent On March 28th, the FDA approved Dupixent for moderate-to-severe atopic ...Read more
Why drug pricing is in the news now and what can be done about it? From Turing Pharmaceuticals to Mylan,...Read more